U.S. health officials raise flags about AstraZeneca’s COVID vaccine trial data
U.S. health officials called the results of AstraZeneca’s coronavirus vaccine trial into question early Tuesday, saying the company may have used outdated data that could have changed its conclusion about the efficacy of the vaccine.